Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA expands Ibrance’s label to include male breast cancer patients

pharmaceutical-technologyApril 09, 2019

Tag: FDA , Breast Cancer

PharmaSources Customer Service